LLMpediaThe first transparent, open encyclopedia generated by LLMs

National Library of Medicine (NLM) Board of Regents

Generated by GPT-5-mini
Note: This article was automatically generated by a large language model (LLM) from purely parametric knowledge (no retrieval). It may contain inaccuracies or hallucinations. This encyclopedia is part of a research project currently under review.
Article Genealogy
Expansion Funnel Raw 79 → Dedup 3 → NER 3 → Enqueued 1
1. Extracted79
2. After dedup3 (None)
3. After NER3 (None)
4. Enqueued1 (None)
Similarity rejected: 2
National Library of Medicine (NLM) Board of Regents
NameNational Library of Medicine (NLM) Board of Regents
Formation1968
HeadquartersBethesda, Maryland
Parent organizationNational Institutes of Health

National Library of Medicine (NLM) Board of Regents is an advisory body that guides the National Library of Medicine on policy, planning, and programmatic priorities, interacting with United States Department of Health and Human Services, National Institutes of Health, and other federal and international institutions. The Board convenes experts from academia, clinical practice, biomedical research, public health, information science, and library professions—drawing members from institutions such as Harvard University, Johns Hopkins University, Mayo Clinic, Centers for Disease Control and Prevention, and World Health Organization. Its work influences initiatives tied to PubMed, ClinicalTrials.gov, Medical Subject Headings, and national efforts linked to National Library of Medicine collections and digital services.

History

The Board was established during a period shaped by policymaking figures including Lyndon B. Johnson and reforms associated with the National Cancer Act of 1971, reflecting broader shifts in biomedical infrastructure alongside institutions like National Institutes of Health and National Library of Medicine. Early deliberations referenced leaders and milestones involving Francis Collins, Donald A.B. Lindberg, and collaborations with university libraries such as Yale University and University of California, San Francisco. Over decades the Board responded to technological change epitomized by transitions from card catalogs to digital services paralleling developments at Library of Congress, innovations by IBM, and standards emerging from National Information Standards Organization and International Organization for Standardization. During public health crises including the HIV/AIDS epidemic and the COVID-19 pandemic, the Board advised on data sharing and resource mobilization in concert with Centers for Disease Control and Prevention, Food and Drug Administration, and international partners such as World Health Organization.

Structure and Membership

Membership typically comprises appointed experts drawn from leading entities like Harvard Medical School, Stanford University School of Medicine, Columbia University, University of Pennsylvania, University of Pittsburgh Medical Center, and representatives from federal agencies including National Institutes of Health and National Library of Medicine. Officers have included directors comparable to figures at National Institutes of Health Office of the Director and presidents from organizations such as Association of American Medical Colleges and American Medical Association. The Board’s composition balances clinical voices from Mayo Clinic, research leaders from Massachusetts Institute of Technology, informatics specialists from Carnegie Mellon University, and library authorities from New York Public Library, ensuring connections to professional bodies like Medical Library Association and to foundations such as Gates Foundation and Andrew W. Mellon Foundation. Appointments and terms reflect precedents set by panels including National Research Council and advisory groups modeled on President's Council of Advisors on Science and Technology.

Roles and Responsibilities

The Board advises on strategic priorities for the National Library of Medicine and its platforms including PubMed Central, MedlinePlus, and ClinicalTrials.gov, informing policies linked to data standards developed by Health Level Seven International and metadata practices endorsed by Dublin Core Metadata Initiative. Responsibilities encompass evaluation of programs funded by entities like National Cancer Institute and coordination with initiatives from National Human Genome Research Institute and National Institute of Allergy and Infectious Diseases. The Board issues guidance on access policies that intersect with intellectual property frameworks such as precedents from United States Copyright Office and public access mandates analogous to NIH Public Access Policy, while liaising with scholarly publishers including Elsevier, Springer Nature, and Wiley-Blackwell. It also recommends priorities for digitization efforts informed by standards from International Federation of Library Associations and Institutions and interoperability goals aligned with Office of the National Coordinator for Health Information Technology.

Meetings and Governance Procedures

Regular meetings follow governance models similar to advisory committees such as the National Advisory Council for Nursing Research and procedural norms from Federal Advisory Committee Act. Agendas examine program reviews, budgetary considerations within frameworks of the United States Department of Health and Human Services and reporting expectations to the United States Congress through briefings analogous to testimonies before the House Committee on Appropriations and the Senate Committee on Appropriations. Minutes and summaries historically document consultations with leaders from National Institutes of Health offices, scholars from Johns Hopkins Bloomberg School of Public Health, and partners from World Health Organization regional offices. Subcommittees and task forces emulate structures used by National Academies of Sciences, Engineering, and Medicine and often include liaisons from Library of Congress and consortia such as HathiTrust.

Relationship with the National Institutes of Health and Other Bodies

The Board functions as an advisory bridge to the National Institutes of Health and to affiliated centers such as National Institute of Mental Health, National Institute of Diabetes and Digestive and Kidney Diseases, and National Heart, Lung, and Blood Institute, coordinating priorities that intersect with funders like Patient-Centered Outcomes Research Institute and policy actors including Office of Science and Technology Policy. It maintains partnerships with professional associations such as American Library Association, Association of Academic Health Sciences Libraries, and International Council of Scientific and Technical Information, while engaging international stakeholders including World Health Organization and regional consortia like European Bioinformatics Institute. The Board’s advisories influence collaborations with publishers, repositories, and standards bodies including CrossRef, ORCID, and DataCite.

Key Decisions and Impact

Notable recommendations have shaped adoption of open access practices comparable to the NIH Public Access Policy and supported expansions of resources like PubMed Central and MedlinePlus that serve clinicians at institutions such as Cleveland Clinic and researchers at Broad Institute. The Board influenced decisions on preservation strategies aligning with initiatives at Library of Congress and digitization efforts resonant with programs at Smithsonian Institution and National Archives and Records Administration. During health emergencies, its counsel affected information dissemination strategies used by Centers for Disease Control and Prevention and data-sharing arrangements involving World Health Organization and Gavi, the Vaccine Alliance, while fostering interoperability advances linking to standards from Health Level Seven International and identity systems such as ORCID.

Category:United States federal boards, commissions, and committees